Allergies or COVID-19: What Are the Differences?
Osteomalacia Vs. Osteoporosis: What's The Difference?
Osteomalacia and osteoporosis are both conditions affecting the bones. Knowing the causes and risk factors for both can help a doctor diagnose your condition.
Bone health is important for a healthy body. Osteoporosis and osteomalacia are two diseases that affect the bones. While they both weaken the bones, they act in different ways.
Knowing the difference between the two can help you talk with a medical professional about your symptoms and get the appropriate diagnosis and treatment.
Osteomalacia and osteoporosis are two different conditions that affect the bones.
Osteomalacia
Osteomalacia is a condition that softens bones. In children, it's called rickets. It involves problems with bone formation and the bone-building process, resulting in the weakening of the bones.
It is most often caused by a vitamin D deficiency, which helps you absorb calcium.
Sometimes the body has trouble absorbing vitamin D, leading to a deficiency. Various health conditions can cause problems with nutrient absorption, including:
Osteoporosis
Osteoporosis occurs when bone mineral density and mass decrease or when the quality or structure of the bone changes. Over time, this can reduce bone strength, increasing the risk of fractures.
The inside of a bone typically has spaces similar to a honeycomb structure. In osteoporosis, these spaces are bigger than in healthy bones, which weakens the bone.
The biggest risk factor for osteoporosis is age. Your body breaks down bone faster than it replaces it, making bones weaker and more prone to fracture. Menopause can also be a risk factor because changes in hormone levels lead to quicker bone loss.
According to research provided by the National Osteoporosis Foundation, osteoporosis is more common in women, with the highest occurrence in white and Asian women.
Can you have both?
It's possible to have both osteoporosis and osteomalacia. Low bone density that could be classified as osteoporosis has been found in up to 70% of people with osteomalacia.
It's important to distinguish this secondary osteoporosis from primary osteoporosis, as the focus and treatment are different.
Diagnosis for each condition is a little different.
Osteomalacia diagnosis
For osteomalacia, a blood test can typically yield a diagnosis. The blood test measures:
Other blood tests may be ordered as well, including those to check for:
Osteoporosis diagnosis
Osteoporosis is usually diagnosed during a routine screening for the condition. Routine screenings are done for women over age 65 years or women of any age who have certain risk factors.
Tools used in making a diagnosis include:
Bone mineral density testing can help:
It uses X-rays to measure the density of the bones.
Treatments for osteomalacia and osteoporosis also differ.
Osteomalacia treatments
If osteomalacia is found early enough, your doctor may recommend vitamin D, calcium, or phosphate supplements. Sometimes, vitamin D is also given intravenously, or through an injection into the vein.
If you have an underlying medical condition that interferes with absorption of vitamin D, treating that condition is necessary as well.
Sometimes children with osteomalacia may need to wear braces or have surgery to fix any bone abnormalities.
Osteoporosis treatments
Treatment for osteoporosis focuses on slowing or stopping bone loss and preventing fractures.
Prevention also depends on the condition.
Osteomalacia prevention
Osteomalacia may not always be preventable, such as if it's due to another medical condition. For osteomalacia due to a lack of sun exposure or vitamin D deficiency, there are things you can do to reduce your risk.
Osteoporosis prevention
To reduce your risk for developing osteoporosis, there are steps you can take to help protect your bones, including:
OSTEOMALACIA OF THE MOTHER AND INTRAUTERINE GROWTH
It has been suggested that vitamin D deficiency in pregnancy may affect fetal growth (BrMedJ1980;280:751-4).
In the present study we measured crown-heel length of the newborn, and free calcium, phosphorous, calcidiol, calcitriol, osteocalcin and intact parathyroid hormone (PTH) in venous cord blood and in serum from 30 Pakistani and 23 Norwegian women just after delivery.
Results: The Pakistani mothers had lower calcidiol levels (mean ± SD) than the Norwegians (p<0,0001); 15,1 +8,6 and 43,1 ±21,3 nmol/l, respectively. There were also lower osteocalcin values in venous cord blood obtained from the Pakistanis (p=0,0005).
None of the Norwegian mothers had intact PTH>5,5 pmol/l, while 43% (13/30) of the Pakistanis had. The crown-heel length of the Pakistani infants in this group were redused (p=0,01) and their mothers had lower free calcium (p=0,003), than the other Pakistani mothers.
Conclusion: Biochemical signs of depressed bone mineralisation were observed in fetuses of Pakistani mothers with vitamin D deficiency. Redused intrauterine growth were observed when the mothers had both vitamin D deficiency and elevated PTH.
Comments
Post a Comment